Cipher Pharmaceuticals Investor Relations Material
Latest events
Q2 2025
Cipher Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cipher Pharmaceuticals Inc
Access all reports
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company focused on dermatology. It acquires, develops, and markets prescription products for skin-related conditions through in-licensed and proprietary therapies. The company is headquartered in Mississauga, Canada, and its shares are listed on the TSX.
Key slides for Cipher Pharmaceuticals Inc
Q1 2025
Cipher Pharmaceuticals Inc
Q1 2025
Cipher Pharmaceuticals Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
CPH
Country
🇨🇦 Canada